These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11411388)

  • 21. Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants.
    Fitzsimons D; François G; Hall A; McMahon B; Meheus A; Zanetti A; Duval B; Jilg W; Böcher WO; Lu SN; Akarca U; Lavanchy D; Goldstein S; Banatvala J; Damme PV
    Vaccine; 2005 Jul; 23(32):4158-66. PubMed ID: 15964484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. JCVI response on hepatitis B vaccination.
    Joint Committee on Vaccination and Immunisation
    Lancet; 2012 Mar; 379(9818):803. PubMed ID: 22386032
    [No Abstract]   [Full Text] [Related]  

  • 23. [National hepatitis B vaccination closer to implementation, but not soon enough: recommendations from the Dutch Health Council].
    Gunning-Schepers LJ; Houweling H
    Ned Tijdschr Geneeskd; 2001 Aug; 145(32):1572-3. PubMed ID: 11525094
    [No Abstract]   [Full Text] [Related]  

  • 24. [Immunization against hepatitis B].
    Domínguez Rojas V
    Av Odontoestomatol; 1986; 2(6):303-5, 307-9. PubMed ID: 2950895
    [No Abstract]   [Full Text] [Related]  

  • 25. Disparities in hepatitis B vaccine funding in Australian jurisdictions: limiting access for priority populations.
    MacLachlan JH; Allard NL; Cowie BC
    Aust N Z J Public Health; 2015 Apr; 39(2):192. PubMed ID: 25827189
    [No Abstract]   [Full Text] [Related]  

  • 26. Universal immunization with hepatitis B vaccine- what it will cost.
    Puliyel JM
    Indian Pediatr; 2000 Jan; 37(1):107-10. PubMed ID: 10745402
    [No Abstract]   [Full Text] [Related]  

  • 27. Cost effectiveness and cost benefit of viral hepatitis B vaccination in the Slovak Republic.
    Hudecková H; Straka S; Szilágyiová M; Avdicová M; Rusnáková S
    Cent Eur J Public Health; 2002 Dec; 10(4):146-8. PubMed ID: 12528387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility of healthcare workers in Kenya to hepatitis B: new strategies for facilitating vaccination uptake.
    Suckling RM; Taegtmeyer M; Nguku PM; Al-Abri SS; Kibaru J; Chakaya JM; Tukei PM; Gilks CF
    J Hosp Infect; 2006 Nov; 64(3):271-7. PubMed ID: 16926061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of hepatitis B vaccine coverage by using the national immunization day in Chandigarh.
    Bhatia V; Swami HM
    Indian J Med Sci; 2000 Aug; 54(8):347-9. PubMed ID: 11143750
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficiency of the incorporation of the hepatitis A vaccine as a combined A+B vaccine to the hepatitis B vaccination programme of preadolescents in schools.
    Navas E; Salleras L; Gisbert R; Dominguez A; Bruguera M; Rodríguez G; Galí N; Prat A
    Vaccine; 2005 Mar; 23(17-18):2185-9. PubMed ID: 15755592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Coverage of vaccination against hepatitis B in Poland in 2004].
    Magdzik W; Czarkowski MP
    Przegl Epidemiol; 2006; 60(2):185-92. PubMed ID: 16964668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis-B vaccine introduction into the routine immunization schedule--Andhra Pradesh experience.
    Kiran V
    Indian J Public Health; 2004; 48(2):63-6. PubMed ID: 15709587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of cost-effectiveness of universal hepatitis B immunization in a low-income country with intermediate endemicity using a Markov model.
    Aggarwal R; Ghoshal UC; Naik SR
    J Hepatol; 2003 Feb; 38(2):215-22. PubMed ID: 12547411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of hepatitis B virus immunization.
    Sharfstein J; Wise P
    JAMA; 1996 Mar; 275(12):908; author reply 909. PubMed ID: 8598611
    [No Abstract]   [Full Text] [Related]  

  • 35. [Outcomes of Polish hepatitis B vaccination program in comparison with European Union].
    Magdzik W
    Przegl Epidemiol; 2003; 57 Suppl 1():51-62. PubMed ID: 12921001
    [No Abstract]   [Full Text] [Related]  

  • 36. [Even children should be vaccinated against hepatitis B. Moderate additional costs results in great humanitarian benefits].
    Struve J
    Lakartidningen; 1996 Mar; 93(10):889-92. PubMed ID: 8656791
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hepatitis B vaccination].
    Zhang H
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):197-8. PubMed ID: 12716509
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatitis B immunization policy for India.
    Aggarwal R; Naik SR
    J Assoc Physicians India; 1996 Feb; 44(2):150. PubMed ID: 10999079
    [No Abstract]   [Full Text] [Related]  

  • 39. An economic evaluation of universal infant vaccination strategies against hepatitis B in Thailand: an analytic decision approach to cost-effectiveness.
    Vimolket T; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):693-9. PubMed ID: 16124440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Should universal hepatitis B immunisation be introduced in the UK?
    English P
    Arch Dis Child; 2006 Apr; 91(4):286-9. PubMed ID: 16551785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.